• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去除脂肪肝中炎症基因上的表观遗传抑制标记。

Removal of epigenetic repressive mark on inflammatory genes in fat liver.

机构信息

Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

Frontier Science Center for Immunology and Metabolism, Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of Developmentally Originated Disease, College of Life Sciences, Taikang Center for Life and Medical Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

出版信息

J Gastroenterol Hepatol. 2023 Aug;38(8):1426-1437. doi: 10.1111/jgh.16252. Epub 2023 Jun 18.

DOI:10.1111/jgh.16252
PMID:37332142
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The detailed epigenomic changes during fat accumulation in liver are not clear yet. Here, we performed ChIP-Seq analysis in the liver tissues of high-fat diet and regular chow diet mice and investigated the dynamic landscapes of H3K27ac and H3K9me3 marks on chromatin. We find that the activated typical enhancers marked with H3K27ac are enriched on lipid metabolic pathways in fat liver; however, super enhancers do not change much. The regions covered with H3K9me3 repressive mark seem to undergo great changes, and its peak number and intensity both decrease in fat liver. The enhancers located in lost H3K9me3 regions are enriched in lipid metabolism and inflammatory pathways; and motif analysis shows that they are potential targets for transcription factors involved in metabolic and inflammatory processes. Our study has revealed that H3K9me3 may play an important role during the pathogenesis of NAFLD through regulating the accessibility of enhancers.

摘要

非酒精性脂肪性肝病(NAFLD)是全球最常见的慢性肝病。脂肪在肝脏中积累时的详细表观基因组变化尚不清楚。在这里,我们对高脂肪饮食和常规饮食的小鼠的肝组织进行了 ChIP-Seq 分析,并研究了染色质上 H3K27ac 和 H3K9me3 标记的动态景观。我们发现,激活的典型增强子用 H3K27ac 标记,在脂肪肝的脂质代谢途径中富集;然而,超级增强子变化不大。被 H3K9me3 抑制标记覆盖的区域似乎发生了很大的变化,其峰数和强度在脂肪肝中都减少了。位于丢失的 H3K9me3 区域的增强子在脂质代谢和炎症途径中富集;并且 motif 分析表明,它们是涉及代谢和炎症过程的转录因子的潜在靶标。我们的研究表明,H3K9me3 通过调节增强子的可及性,可能在 NAFLD 的发病机制中发挥重要作用。

相似文献

1
Removal of epigenetic repressive mark on inflammatory genes in fat liver.去除脂肪肝中炎症基因上的表观遗传抑制标记。
J Gastroenterol Hepatol. 2023 Aug;38(8):1426-1437. doi: 10.1111/jgh.16252. Epub 2023 Jun 18.
2
Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.表观遗传学关联研究揭示了大鼠高脂饮食诱导的非酒精性脂肪性肝病中的H3K27乙酰化增强子和失调基因。
Epigenomics. 2022 Dec;14(23):1523-1540. doi: 10.2217/epi-2022-0362. Epub 2023 Feb 22.
3
Epigenetic regulation of key gene of PCK1 by enhancer and super-enhancer in the pathogenesis of fatty liver hemorrhagic syndrome.脂肪肝出血综合征发病机制中增强子和超级增强子对PCK1关键基因的表观遗传调控
Anim Biosci. 2024 Aug;37(8):1317-1332. doi: 10.5713/ab.23.0423. Epub 2024 Apr 24.
4
Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice.在饮食诱导肥胖的小鼠胰腺 β 细胞中,通过全基因组分析鉴定出组蛋白 H3K27 乙酰化特征性的脂肪酸信号。
Diabetologia. 2018 Dec;61(12):2608-2620. doi: 10.1007/s00125-018-4735-7. Epub 2018 Oct 3.
5
[The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].[细胞色素P450在高脂饮食诱导的非酒精性脂肪肝中的作用:基因表达谱分析]
Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):285-290. doi: 10.3760/cma.j.issn.1007-3418.2017.04.010.
6
Hepatic lipid accumulation alters global histone h3 lysine 9 and 4 trimethylation in the peroxisome proliferator-activated receptor alpha network.肝脂质堆积改变过氧化物酶体增殖物激活受体 α 网络中的全局组蛋白 h3 赖氨酸 9 和 4 三甲基化。
PLoS One. 2012;7(9):e44345. doi: 10.1371/journal.pone.0044345. Epub 2012 Sep 4.
7
LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease.LY6D 对于非酒精性脂肪性肝病中的脂质积累和炎症至关重要。
Exp Mol Med. 2023 Jul;55(7):1479-1491. doi: 10.1038/s12276-023-01033-w. Epub 2023 Jul 3.
8
1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.1,2,3,4,6-五没食子酰基-β-D-葡萄糖可改善高脂饮食诱导的非酒精性脂肪肝病,并维持参与脂类动态平衡的基因在小鼠体内的表达。
Biomed Pharmacother. 2020 Sep;129:110348. doi: 10.1016/j.biopha.2020.110348. Epub 2020 Jun 15.
9
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.黄连素改善非酒精性脂肪性肝病中的糖异生和脂质代谢。
BMC Endocr Disord. 2017 Feb 28;17(1):13. doi: 10.1186/s12902-017-0165-7.
10
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.

引用本文的文献

1
Identification of IL-34 and Slc7al as potential key regulators in MASLD progression through epigenomic profiling.通过表观基因组分析鉴定IL-34和Slc7al为非酒精性脂肪性肝病进展中的潜在关键调节因子。
Epigenomics. 2025 Apr;17(5):281-295. doi: 10.1080/17501911.2025.2467028. Epub 2025 Feb 16.